• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director General Atlantic, L.P. sold $259,760,000 worth of shares (17,000,000 units at $15.28) (SEC Form 4)

    5/21/25 7:01:06 PM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    GENERAL ATLANTIC, L.P.

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Alignment Healthcare, Inc. [ ALHC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/19/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.001 per share 05/19/2025 S(1) 17,000,000 D $15.28 44,302,175 I See footnote(2)(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    GENERAL ATLANTIC, L.P.

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GENERAL ATLANTIC GENPAR, L.P.

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    General Atlantic Partners 95, L.P.

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAP COINVESTMENTS III, LLC

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAP COINVESTMENTS IV, LLC

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAP Coinvestments V, LLC

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAPCO GMBH & CO KG

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC GMBH
    LUITPOLDBLOCK AMIRAPLATZ 3

    (Street)
    MUNCHEN 2M 80333

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAPCO MANAGEMENT GMBH

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC GMBH
    LUITPOLDBLOCK AMIRAPLATZ 3

    (Street)
    MUNCHEN 2M 80333

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    GAP Coinvestments CDA, L.P.

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    General Atlantic (SPV) GP, LLC

    (Last) (First) (Middle)
    C/O GENERAL ATLANTIC SERVICE CO., L.P.
    55 EAST 52ND STREET, 33RD FLOOR

    (Street)
    NEW YORK NY 10055

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 17,000,000 shares of Common Stock on May 19, 2025 at a net price per share of $15.28.
    2. Reflects (i) 43,993,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)
    3. (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are five members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.
    Remarks:
    GA ALN, the GA Funds, GAPCO Management, GA GenPar, GA SPV and GA LP may be deemed to be members of a "group" for the purposes of the Securities Exchange Act of 1934. Each reporting person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by the reporting person. This report shall not be deemed an admission that the reporting persons are a member of a group or the beneficial owner of any securities not directly owned by the reporting person. Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Form 1 of 2
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    /s/ Michael Gosk 05/21/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ALHC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    5/8/2024$6.00 → $8.00Neutral → Overweight
    Piper Sandler
    3/6/2024$4.50Underweight
    Barclays
    3/6/2024$12.00 → $6.00Overweight → Neutral
    Piper Sandler
    1/24/2024$11.00Buy
    Stifel
    More analyst ratings

    $ALHC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Alignment Healthcare Inc.

      SCHEDULE 13G - Alignment Healthcare, Inc. (0001832466) (Subject)

      7/10/25 5:38:44 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • SEC Form 144 filed by Alignment Healthcare Inc.

      144 - Alignment Healthcare, Inc. (0001832466) (Subject)

      6/16/25 4:31:27 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Alignment Healthcare, Inc. (0001832466) (Filer)

      6/11/25 5:06:16 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

      ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

      6/10/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

      ORANGE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Sebastian Burzacchi will join as the new chief operating officer of its management services organization (MSO), and Andreas Wagner will serve as chief people officer, effective immediately. Sebastian Burzacchi, Chief Operating Officer of MSOReporting to Alignment founder and CEO John Kao, Sebastian Burzacchi will direct initiatives that strengthen a core value of the company – supporting doctors. This includes a focus on enhancing provider partnerships and ensuring a seamless experience for doctors with Alignment. "We are thrilled to welcome Sebastian to our leadership team, br

      1/9/24 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide

      ORANGE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- Alignment Health — a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage company — today announced the appointment of Melinda Kimbro as its new chief people officer. Kimbro joined on June 30 to lead the company's human resources (HR) function and will oversee all aspects of the Alignment employee experience, including talent acquisition, culture, diversity, equity and inclusion, total rewards, and facilities. She will also spearhead the strategic development of internal talent to help further drive innovation and provide rich, ongoing career growth opportunities for employees. "Championing ou

      7/6/23 8:00:00 AM ET
      $ALHC
      $VSAT
      Medical Specialities
      Health Care
      Radio And Television Broadcasting And Communications Equipment
      Technology

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Kao John E covered exercise/tax liability with 33,319 shares and sold $2,413,800 worth of shares (180,000 units at $13.41), decreasing direct ownership by 0.68% to 4,888,586 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      7/11/25 5:14:37 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: Chief Executive Officer Kao John E covered exercise/tax liability with 35,801 shares, decreasing direct ownership by 2% to 2,310,972 units (SEC Form 4)

      4/A - Alignment Healthcare, Inc. (0001832466) (Issuer)

      7/11/25 5:07:58 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Chief Executive Officer Kao John E sold $1,302,849 worth of shares (90,000 units at $14.48) (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      6/17/25 7:42:56 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

      ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/45vdkr4b A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will re

      7/10/25 4:05:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars

      ORANGE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that a federal court ruled in its favor on June 9 in a legal challenge against the Centers for Medicare & Medicaid Services (CMS), resulting in an increase in its Arizona HMO 2025 star rating from 3.5 to 4 stars. As a result of the decision, 100% of Alignment's Medicare Advantage members are now enrolled in plans rated 4 stars or higher. "This decision affirms the quality of care we deliver and recognizes the importance of accuracy and fairness in the Medicare Advantage Star Ratings program," said John Kao, founder and CEO of Alignment Healthcare. "Our Arizona members can now have ev

      7/8/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

      ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

      6/10/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alignment Healthcare upgraded by Stephens with a new price target

      Stephens upgraded Alignment Healthcare from Equal-Weight to Overweight and set a new price target of $17.00 from $13.00 previously

      12/3/24 7:13:50 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • KeyBanc Capital Markets initiated coverage on Alignment Healthcare

      KeyBanc Capital Markets initiated coverage of Alignment Healthcare with a rating of Sector Weight

      10/11/24 7:29:52 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on Alignment Healthcare with a new price target

      Robert W. Baird initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $10.00

      5/30/24 7:29:29 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      3/18/24 5:27:36 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 5:57:27 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 1:28:35 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/12/24 1:26:14 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Financials

    Live finance-specific insights

    See more
    • Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

      ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/45vdkr4b A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will re

      7/10/25 4:05:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

      Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

      5/1/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

      ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/frtkwokr A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will

      4/11/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care